Provided by Tiger Trade Technology Pte. Ltd.

Evogene

0.4806
-0.0214-4.26%
Pre-market: 0.55500.0744+15.48%05:23 EDT
Volume:41.71K
Turnover:20.57K
Market Cap:7.59M
PE:-0.53
High:0.5095
Open:0.5000
Low:0.4800
Close:0.5020
52wk High:1.50
52wk Low:0.3700
Shares:15.80M
Float Shares:14.46M
Volume Ratio:0.67
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9012
EPS(LYR):-1.0776
ROE:-182.75%
ROA:-37.80%
PB:-2.31
PE(LYR):-0.45

Loading ...

Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate

Benzinga Earnings
·
May 20

Press Release: Evogene Reports First Quarter 2026 Financial Results

Dow Jones
·
May 20

Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short

TIPRANKS
·
May 19

Evogene unit AgPlenus, Bayer discontinue herbicide development project

Reuters
·
May 19

Evogene Ltd expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
May 18

Evogene presents generative AI drug design at Schrödinger European User Group Meeting

Reuters
·
May 12

Evogene schedules first-quarter results conference call

Reuters
·
May 07

Evogene price target raised to $2.25 from $1.75 at Alliance Global

TIPRANKS
·
Apr 13

Evogene files Form 3 for VP Finance Polina Ravzin initial beneficial ownership statement

Reuters
·
Apr 10

Evogene Reports Receipt Of Nasdaq Minimum Bid Price Notification

Reuters
·
Apr 03

Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026

TIPRANKS
·
Apr 03

Evogene receives Nasdaq minimum bid price notification

TIPRANKS
·
Apr 03

Evogene gets Nasdaq notice as shares trade below $1 minimum bid price

Reuters
·
Apr 03

Evogene unit Casterra reports successful mechanized castor field trials in Brazil

Reuters
·
Apr 01

Evogene files to sell 5.08M ordinary shares for holders

TIPRANKS
·
Mar 27

Evogene Director Leon Recanati Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Evogene Ltd. Director Nimrodi Nir Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Evogene Ltd. Director Percy Adrian John Files Initial Beneficial Ownership Statement

Reuters
·
Mar 18

Evogene names Gabi Tarcic as Chief Development Officer in initial beneficial ownership filing

Reuters
·
Mar 18

Evogene names Ilia Zhidkov as Chief Technology Officer in initial beneficial ownership filing

Reuters
·
Mar 18